GENETIC-AF Phase 2B Trial Results Published in the Journal of American College of Cardiology: Heart Failure
May 01, 2019 08:30 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., May 01, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
BioSig To Participate at Heart Rhythm Society’s Scientific Sessions 2019
April 30, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, April 30, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
ARCA biopharma Announces Steering Committee of Leading International Cardiology and Electrophysiology Experts for PRECISION-AF Phase 3 Clinical Trial
April 23, 2019 08:30 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., April 23, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
BioSig Completes Successful Patient Cases at Greenville Memorial Hospital
April 16, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, April 16, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Frank J. Quintero Joins BioSig Technologies Advisory Board
April 09, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, April 09, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
D.A. Wallach Joins BioSig Technologies Advisory Board
March 26, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, March 26, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Completes Private Placement
March 14, 2019 09:18 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, March 14, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), today announced the closing of a private placement of the Company’s common stock for gross proceeds of...
BioSig Technologies to Present at the LD Micro Virtual Conference
March 08, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, March 08, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal...
BioSig Technologies to Present at the 31st Annual ROTH Conference
March 07, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, March 07, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal...
BioSig Appoints Barry Keenan as Vice President of Engineering
March 06, 2019 07:52 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, March 06, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...